Intravenous thrombolysis (IVT) with recombinant tissue plasminogen activator (r-tPA) is the standard treatment for acute ischemic stroke (AIS) within the first four and a half hours of symptom onset 1 , and five recent clinical trials demonstrated better clinical outcomes when mechanical thrombectomy with stentrievers were performed as an adjunctive treatment to IVT for patients presenting large vessel occlusions within the first six hours of symptom onset 2, 3, 4, 5 . However, those trials lacked sufficient power to evaluate the clinical outcomes of patients presenting carotid tandem occlusions. Carotid tandem occlusions are defined as both extra-cranial occlusion or stenosis of the internal carotid artery (ICA) and downstream intracranial vessel occlusion, which comprises a subgroup of patients that usually present poor recanalization rates under IVT and poor clinical outcomes 6 . Despite of the lack of clinical data from randomized trials on the best management course of acute carotid tandem occlusions, a combined recanalization strategy by means of carotid artery stenting and mechanical thrombectomy has recently shown promising results 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 . We aimed to assess the clinical and radiological data of patients who underwent carotid artery stenting (CAS) and 
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meTHoD Study design, patients, and endpoints
We retrospectively evaluated the clinical and radiological data of a consecutive series of patients who were treated for AIS due to carotid tandem occlusions by means of CAS and endovascular treatment of acute ischemic stroke from January 2009 to December 2014 by the stroke team of the Ribeirão Preto Medical School, University of São Paulo. The inclusion criteria to our study were endovascular treatment with carotid stent for acute ischemic stroke. The criteria for considering tandem occlusion in the current study was an extra-cranial occlusion or stenosis (> 50%) of the internal carotid artery (ICA) and a downstream intracranial vessel occlusion visualized by digital subtracted angiography.
This study was approved by the ethics committee of our Institution, and the review board waived the need for written informed consent from the participants. The patients were selected for endovascular treatment according to our institution's acute stroke protocol for recanalization strategies, which has been previously published 26 . The primary composite endpoint was the complete or partial recanalization rate immediately after endovascular procedure and absence of symptomatic intracranial hemorrhage (sICH) at 72 hours. The secondary endpoints were recanalization times, procedure duration, and clinical outcomes at three-month follow-up.
A total of 20 patients were included in the study, of which 12 (60%) underwent intravenous r-tPA and endovascular treatment, and 8 (40%) had endovascular treatment alone. Among the 8 patients who did not received intravenous r-tPA, 5 patients were admitted beyond 4.5 hours from symptoms onset, 2 patients were using anticoagulation medications, and 1 patient had a recent open surgery. Tables 1  and 2 summarize the study sample and individual patient baseline data, respectively.
Regarding the occlusion site, 14 patients (70%) presented proximal internal carotid occlusions associated with additional intracranial occlusion and six patients (30%) presented carotid stenosis (> 50%) and an intracranial occlusion ( Table 2 ).
All patients were examined by independent certified vascular neurologists at hospital admission, who measured their neurological deficits using the National Institutes of Health Stroke Scale (NIHSS). Three brain CT scans were obtained; a first CT was done at admission, and a second and third brain CT scan was obtained within 24 hours and at 72 hours after treatment, respectively. We defined symptomatic intracranial hemorrhage according to the SITS-MOST definition: a PH-2 (blood clot exceeding 30% of the infarcted volume with significant space occupying effect) or subarachnoid hemorrhage on the post-treatment imaging scan leading to a decline in NIHSS of ≥ 4 points or causing death (modified Rakin scale -mRS 6) within 36h 27 . The neurologic outcomes of patients were assessed using the mRS at three-month follow-up through electronic medical records or telephone conference. Time from symptom onset to recanalization and procedure duration were recorded. The procedure duration began with the groin puncture and ended at the instant of maximal recanalization. Recanalization was assessed using the thrombolysis in cerebral infarction score (TICI). As originally described, TICI categories span from no perfusion (grade 0) to complete perfusion (grade 3) 28, 29 . The "partial perfusion" category (grades 1, 2a and 2b) was used in this study accordingly to the modified version of the original TICI score 30 . In the modified version of TICI score the grade 1 was defined as antegrade reperfusion past the initial occlusion, but limited distal branch filling with little or slow distal reperfusion; grade 2a as an antegrade reperfusion of less than half of the occluded target artery previously ischemic territory (eg, in 1 major division of the MCA and its territory); and grade 2b as an antegrade reperfusion of more than half of the previously occluded target artery ischemic territory (eg, in 2 major divisions of the MCA and their territories).
Neurointerventional procedure
For the endovascular treatment in general we performed local anesthesia with conscious sedation. Intubation of patients was performed whenever necessary (indications mainly included extreme patient agitation, neurologic deterioration, pulmonary or cardiac complications). All of the procedures were performed using femoral artery access. An intravenous bolus of 5,000 IU of standard heparin was administered after the puncture if intravenous r-tPA was not previously infused. If r-tPA was infused prior to the endovascular procedure, no heparin was administered after the femoral puncture. The general antiplatelet regimen that was recommended was aspirin (300 mg/daily) and clopidogrel (75 mg/daily) that was started at 24 hours after treatment and maintained during 3 months. After three months, we indicated only aspirin (100 mg/daily). For patients for whom an anticoagulant was indicated aiming secondary stroke prevention, like patients presenting atrial fibrillation, an association of aspirin (100 mg/daily) and Warfarin sodium was indicated. A 7-Fr guiding catheter (Guider Softip; Boston Scientific, Natick, MA) or a 6-Fr guiding catheter (Neuron; Penumbra, Alameda, CA) was introduced through a femoral sheath into the ICA. Carotid artery stenting was performed using a Wallstent (Boston Scientific, Natick, MA, USA) and a 5.5 or 6.0 x 20 mm, 153 cm, Monorail postdilatation balloon (Boston Scientific, Maple Grove, MN). After stenting, if a thrombus was still occluding cervical ICA, than we performed a manual thrombus aspiration across cervical internal carotid using a 60 cc syringe connected through the guiding catheter. After that, for recanalization of intracranial artery we performed intra-arterial infusion of rTPA or mechanical thrombectomy using the Solitaire-FR device (Microvention-Covidien, Irvine, CA). Successful recanalization was defined as a TICI score of 3 or 2b in all of the treatable vessels. If the treatable vessel was not opened to a minimum of TICI 2b after a maximum of five passes of the thrombectomy device, the treatment was considered a failure 26 .
Statistical analysis
Categorical variables were presented as numbers and percentages. Continuous variables were presented as mean (range, ± standard deviation (SD)) or median and interquartile ranges.
ReSuLTS
Among all cases reported in this series, carotid angioplasty stenting was performed for all patients. Three patients (15%) received intra-arterial r-tPA for recanalization of intracranial artery right after carotid stent placement, because these three cases were treated before stentriever become available at our institution. After that, all cases were performed using a stentriever for recanalization of intracranial vessels.
The primary endpoint (i.e., complete or partial recanalization of the intracranial occlusion graded and no sICH) was achieved in 17 patients (85%). The recanalization rate (TICI 2b or 3) was achieved in 18 patients (90%), whereas a sICH was observed in one patient (5%). N: no; IA: intra-arterial thrombolysis with rTPA plus fragmentation of thrombi using wire and microcatheter;
MT: mechanical thrombectomy with Solitaire stentriever; NIHSS: National Institutes of Health Stroke Scale; mRs: modified Rankin scale; TICI: thrombolysis in cerebral infarction score.
The secondary endpoints were a mortality rate of 20% (4 patients) at three-month follow-up. One patient who had no recanalization (TICI score = 0) died after three days because of a brain infarction edema, two patients died because of systemic infections, and one died because of a refractory cardiac arrhythmia. At three months, 35% (7/20) of the patients had mRS score ≤ 2. The mean recanalization time was 336 ± 119.7 (SD) minutes (ranging from 157 to 586 minutes) and the mean procedure duration was 89 ± 46.9 (SD) minutes (ranging from 51 to 240 minutes). We had no complications related to the anesthesia, and no procedural related complications like vessel ruptures, arterial dissections or inadvertent Solitaire (Microvention-Covidien) detachment. Figures 1 and 2 illustrate two successful endovascular procedures.
DISCuSSIoN
Carotid atherosclerotic stenosis is associated with approximately 15-20% of all ischemic strokes. Acute carotid tandem occlusions are a relatively common presentation of AIS; approximately 25% of patients with middle cerebral artery (MCA) occlusion will have a concomitant ICA occlusion, and 50% of patients with an ICA occlusion will have a proximal MCA occlusion. Acute carotid tandem occlusions have been reported to have low recanalization rates and poor outcomes even after IVT 7 . Recent randomized trials represent a landmark for endovascular treatment of AIS due to large vessel occlusions 2, 3, 4, 5 . Despite the fact that patients presenting acute carotid occlusions have large vessel occlusions and would thus probably benefit of the endovascular approach, recent randomized trials were not designed and powered to assess the outcomes of this specific subgroup of patients. This study showed a primary endpoint of recanalization without a sICH in 85% of patients (17/20) . Our results were in accordance with results of previous similar studies (Table 3) 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 . Furthermore, this study showed rates of recanalization, sICH, and mortality that were similar to those found in recent randomized trials on thrombectomy for acute stroke 2, 3, 4, 5 . Although implanting a carotid stent in the setting of AIS may increase the risks of in-stent thrombosis or intracranial hemorrhage because of the double anti-platelet regime, we had no cases of acute in-stent thrombosis and only one case (5%) of sICH. In addition, mortality rate of 20% and the good neurologic outcome of 35% at 3 months were in accordance with previous similar studies and recent trials (Table 3) .
Regarding recanalization and procedure duration, we achieved an average recanalization and procedure duration times of 336 minutes (5.6 hours) and 89 minutes (1.5 hour), respectively. These times were longer than the times usually obtained with mechanical thrombectomy alone. This finding may be explained by the two-in-one characteristic of the procedure, which is compounded by a carotid artery stenting and a mechanical thrombectomy.
Regarding the procedure technique, the best recanalization strategy for carotid tandem occlusions remains controversial. Some authors have reported a cerebral artery recanalization first, by passing cervical carotid occlusion or through one of the communicating arteries at the level of the circle of Willis 30 . On contrary, we routinely indicated a . Second, CAS prevents the risk of acute proximal or distal artery reoclusions or recurrent cerebral embolism. Third, mechanic thrombectomy requires positioning a guiding-catheter into the internal carotid artery distal to the proximal carotid lesion. Therefore, CAS using a close-cell stent allows the guiding catheter to safely cross the proximal carotid lesion thorough the struts of the stent allowing for intracranial clot removal 23 . Fourth, recanalization of proximal carotid lesion may have advantages of improve collateral flow to the ischemic tissue, improve local perfusion pressure and delivers fresh blood to the intracranial occlusion site to facilitate endogenous thrombolysis, which may lead to immediate recanalization or to delayed recanalization even in the case of failed distal mechanic thrombectomy.
The results obtained in the present study were consistent with results of previous similar non-randomized studies that showed good outcomes with CAS and mechanical thrombectomy to treat patients presenting carotid occlusions. Although the studies reviewed are in most observational, which may have selection bias, the main results seem to be reproducible across studies (Table 3) . Therefore, a pooled analysis of randomized trials to assess the best revascularization strategy for carotid tandem occlusions appear to be justified. In addition, the best antiplatelet and anticoagulation regimens, an ideal stent design and the best procedure protocol for each carotid lesion etiology need to be clarified.
The limitations of this study were the retrospective design, the small size and single-center sample and the lack of a control group.
In conclusion, a revascularization strategy with carotid angioplasty stenting and endovascular treatment of acute ischemic stroke due to carotid tandem occlusions appears effective without an increase of sICH. 
